BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 10492661)

  • 21. Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain.
    Lecha M
    Br J Dermatol; 2001 Oct; 145 Suppl 60():21-6. PubMed ID: 11777261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Itraconazole pulse therapy in the treatment of disto-lateral subungual onychomycosis.
    Aman S; Akbar TM; Hussain I; Jahangir M; Haroon TS
    J Coll Physicians Surg Pak; 2003 Nov; 13(11):618-20. PubMed ID: 14700485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
    Casciano J; Amaya K; Doyle J; Arikian S; Shear N; Haspel M; Kahler K
    Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole.
    De Doncker P; Decroix J; Piérard GE; Roelant D; Woestenborghs R; Jacqmin P; Odds F; Heremans A; Dockx P; Roseeuw D
    Arch Dermatol; 1996 Jan; 132(1):34-41. PubMed ID: 8546481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis.
    Sigurgeirsson B; Billstein S; Rantanen T; Ruzicka T; di Fonzo E; Vermeer BJ; Goodfield MJ; Evans EG
    Br J Dermatol; 1999 Nov; 141 Suppl 56():5-14. PubMed ID: 10730908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of pulse therapy with terbinafine tablets and topical terbinafine cream for the treatment of dermatophyte onychomycosis: a pilot study.
    Nakano N; Hiruma M; Shiraki Y; Chen X; Porgpermdee S; Ikeda S
    J Dermatol; 2006 Nov; 33(11):753-8. PubMed ID: 17073989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fifth toenail clinical response to systemic antifungal therapy is not a marker of successful therapy for other toenails with onychomycosis.
    Avner S; Nir N; Henri T
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1194-6. PubMed ID: 17062030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group.
    Tausch I; Bräutigam M; Weidinger G; Jones TC
    Br J Dermatol; 1997 May; 136(5):737-42. PubMed ID: 9205509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of itraconazole pulse therapy for onychomycosis. An update.
    De Doncker P; Gupta AK; Cel Rosso JQ; Daniel CR; Rosen T; Verspeelt J; Marynissen G; Meuleneers L; Moskovitz B; Jacko M; Shear N; Odom RB; Aly R; Scher RK; Elewski BE
    Postgrad Med; 1999 Jul; Spec No():17-25. PubMed ID: 10492662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy of continuous and pulse dose terbinafine regimes in toenail dermatophytosis: A randomized double-blind trial.
    Yadav P; Singal A; Pandhi D; Das S
    Indian J Dermatol Venereol Leprol; 2015; 81(4):363-9. PubMed ID: 26087080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group.
    Evans EG; Sigurgeirsson B
    BMJ; 1999 Apr; 318(7190):1031-5. PubMed ID: 10205099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study.
    Amichai B; Nitzan B; Mosckovitz R; Shemer A
    Br J Dermatol; 2010 Jan; 162(1):46-50. PubMed ID: 19785609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two novel itraconazole pulse therapies for onychomycosis: a 2-year follow-up.
    Avner S; Nir N; Baruch K; Henri T
    J Dermatolog Treat; 2006; 17(2):117-20. PubMed ID: 16766337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The new oral antifungal agents for onychomycosis of the toenails.
    Gupta AK; Shear NH
    J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):1-13. PubMed ID: 10565624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulsed versus continuous terbinafine dosing in the treatment of dermatophyte onychomycosis.
    Pavlotsky F; Armoni G; Shemer A; Trau H
    J Dermatolog Treat; 2004 Sep; 15(5):315-20. PubMed ID: 15370400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of dermatophyte onychomycosis with three pulses of terbinafine (500 mg day for a week).
    Takahata Y; Hiruma M; Shiraki Y; Tokuhisa Y; Sugita T; Muto M
    Mycoses; 2009 Jan; 52(1):72-6. PubMed ID: 18444971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, double-blind, comparative study on efficacy and safety of itraconazole pulse therapy and terbinafine pulse therapy on nondermatophyte mold onychomycosis: A study with 90 patients.
    Ranawaka RR; Nagahawatte A; Gunasekara TA; Weerakoon HS; de Silva SH
    J Dermatolog Treat; 2016 Aug; 27(4):364-72. PubMed ID: 26651495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents.
    Piraccini BM; Sisti A; Tosti A
    J Am Acad Dermatol; 2010 Mar; 62(3):411-4. PubMed ID: 20159308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Terbinafine versus itraconazole: a controlled clinical comparison in onychomycosis of the toenails.
    Bräutigam M
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S53-6. PubMed ID: 9594938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.